The Aotearoa New Zealand Rare Disorders Strategy sets out the direction for the health system to better support people and their whānau living with rare disorders.
Associate Health Minister David Seymour says he has set clear expectations for Pharmac around delivering the medicines and medical technology that Kiwis need.
The Government Policy Statement on Health 2024-27 is the public statement of what Government expects the health system to deliver and achieve, and how success will be measured, monitored, and reported.
The framework for the baseline survey on human rights was developed in alignment with the four articles of Te Tiriti o Waitangi.
This report shows information on funding to Māori health providers by the Ministry of Health, Te Whatu Ora and Te Aka whai Ora for the period 2018/19 to 2022/23. This report follows on from our reports in 2017, 2021 and 2022 on the same topic and is part of our monitoring of Whakamaua: Māori Health Action Plan 2020-2053.
The Waitangi Tribunal’s Health Service and Outcomes Inquiry (Wai 2575) is an inquiry into the Crown’s response to health inequities experienced by Māori.
The Ministry of Health’s Te Tiriti o Waitangi (Te Tiriti) Framework provides an updated expression of the Crown’s Te Tiriti obligations in the context of the health and disability system.
As part of the health system transformation a range of strategies have been developed to help guide our health system to achieve pae ora, healthy futures.
Te Pātaka Whaioranga – Pharmac acknowledges Te Mana o Te Tiriti o Waitangi and the ongoing partnership it instils between the Crown and Māori. Through our work on behalf of Aotearoa / New Zealand, we strive to improve equitable health outcomes for Māori.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI